Kenneth Shain

20PUBLICATIONS
191CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 23, 2026
Unc-51 like kinase 3 (ULK3) contributes to autophagy and cell survival in multiple myeloma.

|Jul 02, 2026
Real-world outcomes with BCMA- and GPRC5D-targeting bispecific antibodies in plasma cell leukemia.

|Jun 11, 2026
Product-intrinsic NF-κB-driven transcriptional programs connote durability of CAR-T response in multiple myeloma.

|Jun 03, 2026
Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma.

|May 11, 2026
Patient-reported outcomes after idecabtagene vicleucel vs. ciltacabtagene autoleucel CAR-T for multiple myeloma.

|Feb 02, 2026
Causal Effects of Hydrophilic Bile Acids on Carfilzomib-Related Cardiovascular Events in Multiple Myeloma: A Mendelian Randomization Study.

Samia Shabnaz, Eric Farber-Eger, Marwa Tantawy

Pageof 4

Frequent Collaborators

10 joint publications

Rachid C Baz

9 joint publications

Taiga Nishihori

6 joint publications

Omar Castaneda Puglianini

5 joint publications

Praneeth Sudalagunta